Major players in the wearable ecg monitors market are Apple, GE Healthcare, Withings, Samsung, QardioCore, AliveCor, Fitbit, Welch Allyn, Philips Healthcare, CardioNet. The global wearable ecg monitors market is expected grow from $1.
New York, May 07, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Wearable ECG Monitors Global Market Report 2021: COVID 19 Growth And Change to 2030" - https://www.reportlinker.com/p06070196/?utm_source=GNW
54 billion in 2020 to $1.63 billion in 2021 at a compound annual growth rate (CAGR) of 5.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $2.14 billion in 2025 at a CAGR of 7%.
The wearable ECG monitor market consists of sales of ECG monitors embedded with optical sensors and designed to be affixed to a limb of human (patient) body to monitor physiological information anytime and anywhere.The market consists of revenues generated by establishments that are primarily engaged in the manufacturing of diagnostic wearable ECG monitors.
An ECG records the tiny electrical signals that are generated by the beating of patient’s heart. An ECG provides data on the heart rate, the rhythm, the state of the conduction system and muscle tissue (heart attacks), and even the level of certain chemicals like potassium in the blood, and the effect of medication.
The wearable ECG monitors market covered in this report is segmented by type into wired, wireless and by application into atrial fibrillation, angina, atherosclerosis, cardiac dysrhythmia, congestive heart failures (CHF), coronary artery disease, heart attack, bradycardia, tachycardia.
rise about 23.6 million by 2030. According to Centers for Disease Control and Prevention, one person dies every 36 seconds in the USA from CVD. CVD account for nearly 836,546 deaths in the US alone. Cardiovascular diseases that include abnormalities in heart rhythm such as atrial fibrillation, ventricular fibrillation, and atrioventricular block require long-term monitoring. Additionally, since the mortality rate is high in CVD patients, the need for wearable devices that enable continuous heart monitoring is critical. The increasing incidence of cardiovascular diseases is therefore driving the market for wearable ECG monitors for a quick emergency response and earlier detection of heart malfunctioning
Wearable ECG monitors employ electrodes that contact the skin directly in order to monitor the health state and signal/trigger alarm to the care providers.However, currently the requirement is the electrodes that are non-contact with the human body.
This is because by using the electrodes that are in contact with human body, the body’s movement may be easily superimposed on the detected ECG signal, and for a steady monitoring of ECG signal, it is necessary to effectively remove the motion artefact from the ECG signal. Therefore, wearable ECG monitors employing electrodes in contact with human body and causing motion artifacts is likely to challenge the market.
With the increasing incidence of cardiovascular diseases (CVD), there has been a growing interest in developing wearable devices that can continuously monitor cardiac activity. According to American Heart Association’s Heart Disease and Stroke Statistics 2019, there are around 17.9 million deaths annually worldwide, and this number is expected to
Prolonged ambulatory rhythm monitoring is crucial for the diagnosis of intermittent arrhythmia.Conventional technologies for non-invasive rhythm monitoring include Holter monitoring or external cardiac event recorders.
However, these traditional technologies have limitations in term of low sensitivity, low diagnostic yield, and poor patient compliance.Although implantable cardiac monitors (ICMs) help in long-term monitoring, it is an invasive method as it requires minor surgery and is also associated with significant costs.
Therefore there is an increasing demand for non-invasive ambulatory rhythm monitoring. Smart clothing technology is a novel, alternative tool for non-invasive ambulatory rhythm monitoring.
In July 2019, BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, acquired ADEA Medical AB, an early-stage Swedish medical technology company that delivers remote health services in the Nordics. The acquisition is aligned with BioTelemetry’s longer-term strategy to increase its international footprint and offer its products and services to physicians and patients in the Nordics and other parts of Europe.
Read the full report: https://www.reportlinker.com/p06070196/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001